text:
Local Agents. Amazing Results.
We believe all real estate is local - that's why we employ the best local agents in our different markets to get the best local results. Knowledge is power. And Marketing is everything in our business. We will make your home look as good as possible with our cutting edge marketing materials, photography and film making.


text:
well hello there! long time no blog!!
i've been away a while, focussing on my latest project: myself. i've been on somewhat of a dietary and training mission, but this is not a fitness blog (well, not yet anyways) and that is a subject for another day.
the point i'm getting to, in a rather round about fashion, is that i've been so preoccupied, it wasn't until a friend sent me the link to apartment therapy's round up of diy advent calendars that i realised how slack i've been in my usually frenzied Christmas preparations! it's time to crack on with husband's advent calendar. so, this is my diy version i'd like to share with you.
(what seems like) many years ago, i bought a stocking and sewed 25 squares of fabric cut from an old pair of trousers onto the back. then every year, i make a puzzle for husband to complete during advent.
apart from the initial cost of the stocking, which has already given me more than my money's worth, it costs next to nothing each year. it just calls for a little time and some imagination…
… and if you're short on either, you could always simply cut up a picture you like from a magazine or off t'interwebs, a Christmas card or photo.
this is last year's puzzle, completed with relative ease:
this one's an oldie that gave husband a bit of a headache!:

subset: commoncrawl


text:
Moms love our Luxuriously soft and breathable pajama set.
- Snug fit for safety and warmth
- Stretchy bamboo rayon fabric for extra comfort and movement
- Tight fitting to comply with the CPSIA regulations (Consumer Product Safety Improvement Act in USA) and Health Canada Children's Sleepwear Requirement.
Fabric: 97% rayon from bamboo 3% spandex
Size: 12-18M / 18M-24M / 2T / 3T / 4T / 5T


text:
Model #FYI-2448
|List Price:
|Our Price:
General Description
We're committed to exceeding your expectations:
- Found it for less? We'll match the price
- 25-Year or Limited Lifetime Warranty
Our customers come first — we guarantee it!
The FYI Mobile Flip Chart Whiteboard Easel from MiEN is incredibly versatile. When you want to display a chart or poster, it can simply be clipped onto the easel. The whiteboard surface is great for writing notes or illustrating an important point. An innovative flipping feature offers various vertical, horizontal and angled work surface positions.
With a flexible design, this flip chart whiteboard easel accommodates various configurations. Height adjusts from sitting height to standing height so presenters can use it in any position. Magnetic telescopic arms secure various sizes of large paper pads. If you are looking for a whiteboard easel for training sessions, presentations or classroom use, this flexible option is excellent.
- Manufacturer:
- MiEN Company
- Width:
- 25.25 in.
- Length:
- 26.7 in.
- Height:
- 59-74.8 in.
- Weight:
- 76 lbs.
- Casters:
- Hooded, Dual Wheel, Nylon
- Frame Material:
- Steel
- Warranty:
- Limited Lifetime
- Smooth Writing: Whiteboard surface works well with dry erase markers in your colors of choice.
- Convenient: Magnetic surface lets you hang notes or fliers.
- Adjustable Height: Height adjusts from from sitting position to standing height
- Flexible Design: Two concealed hooks and two magnetic telescopic arms accommodate various sizes of large paper pads up to 24x48".
- Versatile Positioning: Board flips into horizontal position for use as a writing surface or laptop cart.
- Sturdy Support: Tubular steel frame has a powder-coated finish.
- Smooth Rolling: Easily glides to a destinations on hooded dual-wheel casters.
- Lifetime Coverage: Our Limited Lifetime Warranty guarantees many years of use and enjoyment.
We're committed to exceeding your expectations:
- Found it for less? We'll match the price
- 15-Year or Limited Lifetime Warranty
Our customers come first — we guarantee it!
Shipping & Assembly
- Ships Via:
- Common Carrier
- Leaves Factory In:
- Approximately 2-3 weeks
- Assembly:
- Required
- Average Assembly Time:
- 15 minutes
MiEN FYI Mobile Flip Chart Whiteboard Easel
|List Price:
|Our Price:


text:
The British pound is under further pressure today, falling for a third straight day after the terror attack in Manchester that left 22 people dead and scores more injured.
At 4.45pm (GMT) the British currency was trading at $1.2940 against its US counterpart, down from $1.2962 in yesterday's trading.
Police in the UK believe that the suicide bomber who carried out the terrorist attack, didn't act alone and that another attack may happen, which may keep the pound under pressure for the foreseeable future.
There is also the question of Brexit negotiations to come and as each day goes by, many are starting to predict that Britain is headed for a "Hard Brexit" which will cause the pound to suffer further losses.
The Elections coming up this month in which British Prime Minister Theresa May is expected to win in a landslide may provide some temporary support for the sterling but many don't expect this to last long
"We've literally gone short on the pound at the end of last week," said Mark Dowding, a fund manager at BlueBay, which oversees $55.5bn in Assets
"We think you're going to be facing a Brexit that to us looks like it's going to be a hard Brexit." He added.
Mr Dowding predicts that the pound could fall below $1.20 as the year unfolds when the results of Brexit negotiations start to filter through to the market.
|By clicking "Continue" you will be redirected to the website operated by FIBO Group Holdings Limited, a company registered in Cyprus and regulated by CySEC. Please familiarize yourself with the Terms of Business through the link. Click "Cancel" to remain on this page.


text:
Meet The Team
Research Team
Prof. John V. Reynolds
Head of Dept. of Surgery
Contact: email@example.com
Amy Buckley
Research Area: Oesophageal Cancer
Contact: firstname.lastname@example.com
Amy completed her BSc in Pharmacology in University College Dublin in 2015. After completion of her undergraduate studies Amy was awarded an Irish Cancer Society Scholarship to carry out her PhD studies in the Department Of Surgery, Trinity College Dublin. Her research focuses on the identification of novel radio-sensitising compounds to improve response to radiation therapy in oesophageal adenocarcinoma (OAC). OAC is an aggressive disease with a very poor prognosis and a dismal cure rate of only 20%.
It is of great concern that the incidence of this cancer in Ireland and in the Western World has increased more rapidly than any other cancer, with a 48% rise in incidence rate over the past 15 years. Surgical treatment of OAC is associated with increased morbidly and mortality rates. Current therapeutic regimes focus on neo-adjuvant treatment (prior to surgery) with chemotherapy alone or chemoradiation (neoCRT) for locally advanced tumours. Unfortunately, only 20-30% of patients show a beneficial response to neo-adjuvant therapy with 70-80% of patients receiving a toxic treatment with no benefit. This major clinical challenge of treatment resistance reinforces the need for the discovery and validation of novel targeted therapies which will increase neo-adjuvant treatment response rates and act as radiosensitisers. An upregulation of angiogenesis, metabolism and DNA repair correlates with treatment resistance in OAC. We hypothesise that our novel family of drugs that inhibit angiogenesis, DNA repair and metabolism of tumour cells will improve treatment response..
Ashanty Rodriguez
Research Area: NKT cells in Oesophageal and Gastric Cancer
Contact: email@example.com
Ms. Ashanty Maggvie Melo Rodriguez completed her undergraduate degree in Clinical Biochemistry at the Universidad de las Americas Puebla, Mexico in 2012. Her final year project was entitled "Evaluation of the immunoreactivity of Ki-67 as indicator in brain tumours" under the supervision of Dr. Luz del Carmen Quiroz. The aim of this project was to evaluate if Ki-67 can be used to indicate the growth fraction of brain tumours in paediatric patients using immunohistochemistry.
Following completion of her undergraduate degree, she then went on to complete an internship in the Department of Pathology at the University Medical Center Groningen in The Netherlands, under the supervision of Prof. Wilfred F.A. den Dunnen. Her roll here was to study the effect of CHIPs on astrocytomas samples via immunohistochemistry. Ms. Rodriguez then moved to Trinity College Dublin to undertake the M.Sc. in Immunology. Her 3 month project focused on the cytokine output of macrophages in the absence of UCP3. The aim of this project was to measure TNFα, IL-1β, IL-10 production by ELISA, and to determine the effect of UCP3 in the oxygen consumption rate and extracellular acidification rate. This project was done under the supervision of Prof. Richard Porter in the Trinity Biomedical Science Institute. During the master she took modules such as Genes and Immunity, Clinical Immunology, Tumour Immunology and Immunotherapeutic and product development. Ashanty was then granted funding from the Government of Mexico to carry out a Ph.D. in the Department of Immunology, School of Medicine in Trinity College Dublin, under the supervision of Dr. Derek Doherty and Dr. Joanne Lysaght. Her Ph.D. project focuses on the use of NKT cells as novel cellular based immunotherapies for oesophageal and gastric cancer patients. This project aims to carry out detailed functional and phenotypic analysis of human NKT cells and importantly to determine the effect of different chemotherapy drugs and radiotherapy on the NKT -cell viability and function.
Dr Cliona Lorton
Research Area: C-Reactive Protein in cancer
Contact: email@example.com
Croi Buckley
Research Area: Colorectal cancer
Contact: email@example.com
Rectal cancer (often described together with cancer of the colon as 'colorectal cancer' or 'bowel cancer') is a common cancer in Ireland and worldwide, with poor survival rates. Chemo-radiation therapy has been demonstrated to be very effective for some patients with rectal cancer to shrink tumours before surgery. However, a large proportion of patients who receive this treatment have a poor response, and their tumours do not decrease in size as intended. This means that patients can often face a delay to surgery, and undergo undesirable effects of radiation without any gain. Previous work in our department has shown that cancer cell metabolism (how cells get their energy to survive and grow) is associated with response to radiation therapy in oesophageal cancer. Building on this research, Croi's project is looking at whether the energy metabolism of rectal cancer cells is also associated with whether or not patients respond to radiation therapy. She is also investigating if we can improve response of cancer cells to radiation, possibly providing a future alternative therapy for patients predicted not to respond to normal treatment. Hopefully in the future, this may allow to us stratify patients according to their predicted response to radiation therapy, to improve their treatment plan and therefore improve their chance at survival.
Dr Stephen Maher
Research Area: Radiation oncology, MicroRNAs
Contact: email@example.com
Dr Joanne Lysaght
Research Area:Cancer Immunology
Contact: firstname.lastname@example.com
In 2008, she began working in the Department of Surgery, TCD/St. James's Hospital. Her research focused on the impact of obesity on anti-tumour immune responses in gastrointestinal cancer patients, with a particular focus on T lymphocytes. In 2009, Dr. Lysaght was awarded a HRB Post-Doctoral fellowship for her work in the area of obesity and tumour immunity. In September 2011, she was appointed Ussher Lecturer in Molecular Oncology and was part of a team who established the award winning M.Sc. in Translational Oncology. She lectures to both undergraduate and postgraduate students in the areas of tumour immunology, inflammation, immunotherapy, tumour microenvironment, oncology and lifestyle factors affecting immunity.
In 2015 Dr. Lysaght was appointed Assistant Professor in the School of Medicine. She has an active research group has authored a number manuscripts in the area of tumour immunity, obesity, immune modulation and lymphocyte trafficking. Other ongoing research projects are examining the impact of obesity on liver inflammation and post-operative recovery, understanding the role of adaptive immunity in the progression of pre-cancerous conditions to cancer, identifying new strategies to harness the immune system to attack or prevent gastrointestinal cancers and understanding the role of the inflammation in wasting conditions such as cancer cachexia.
Dr Margaret Dunne
Research Area: Cancer Immunology
Contact: email@example.com
Current post:
Senior Research Fellow at the Department of Surgery, Trinity Translational Medicine InstituteQualifications:
PhD (2010) Maynooth University
Professional Certificate in Postgraduate Teaching and Learning (2008) Maynooth University
BSc Biotechnology (2005) Maynooth University
Research Background:
Dr Dunne's research interests are focused on elucidating the role of novel innate lymphocyte subsets, such as gamma/delta (γδ) T cells and mucosa-associated invariant T (MAIT) cells, in human health and disease, and how such immunological markers may be used to predict patient clinical outcomes. Studies to date have involved characterisation of T cell subtypes in disorders such as coeliac disease, colorectal cancer and in progression from inflammation to cancer. Dr Dunne's current work involves assessing whether immunological parameters, such as the antigen presenting molecule HLA-DR can predict patient clinical responses in the setting of oesophageal adenocarcinoma (OAC), an aggressive type of cancer. OAC rates are increasing in Ireland and have been predicted to double within the next two decades.
Project Titles:
1. Development of prognostic screening tools to predict patient response to neoadjuvant chemoradiotherapy treatment for oesophageal adenocarcinoma
2. Assessment of the predictive value of immune and histological parameters in oesophageal adenocarcinoma using digital pathology
Research Areas:
Cancer immunology, immunotherapy, translational medicine, γδ T cells, MAIT cells, immune scoring, patient stratification
Aisling Heeran
Research Area: Rectal Cancer
Contact: email@example.com
Dr Melissa Conroy
Research Area: Cancer Immunology
Contact: firstname.lastname@example.com
BSc (Hons): NUI Maynooth
PhD: NUI Maynooth
Irish Research Council Government of Ireland Postdoctoral Fellowship: Targeting T cell trafficking as a novel means to control obesity-associated chronic inflammation.
Research Interests: Cancer, liver disease, chemokines, immunotherapeutics, T cells, NK cells, inflammation, obesity.Obesity is a serious global health problem affecting 500 million adults and over 40 million children worldwide. It is now estimated to be directly responsible for up to 20% of cancer deaths and has the strongest association with oesophageal adenocarcinoma (OAC), of all malignancies. OAC has the fastest growing incidence of all cancers in Ireland and the increasing prevalence of obesity is thought to be one of the main contributing factors for this. Furthermore, obesity is also responsible for increased prevalence of non alcoholic fatty liver disease (NAFLD) which results from altered lipid content and excessive inflammation in the liver. New therapies are urgently required to improve patient survivorship in OAC and to treat and prevent the clinical manifestions of excessive fat in the liver, which are observed in as many as 76% of obese individuals.
The Irish Research Council-funded fellowship is focussed on elucidating the potential of novel chemokine receptor antagonists as an immunotherapeutic target for OAC through which tumour-specific T cell responses can be redirected away from the adipose tissue and liver and toward the tumour. The overall aims of our immunological studies are to improve patient prognosis and survivorship for OAC and alleviate the detrimental complications of obesity in the liver.
Dr Niamh Lynam-Lennon
Research Area: Treatment Resistance in Gastrointestinal Cancer
Contact: email@example.com
Dr Niamh Lynam-Lennon graduated from Dublin City University with a B.Sc. in Analytical Science in 2007 and received her PhD in cancer biology from Trinity College Dublin in 2011. Dr Lynam-Lennon is currently a Research Assistant Professor in the Dept. of Surgery, Trinity College Dublin, where she leads a research group in the area of chemoradiation therapy resistance in gastrointestinal cancer. Her research interests are focused on two main areas; prediction of response to therapy and identification of novel treatment strategies to enhance the tumour response to therapy, with the ultimate goal of improving treatment and survival for patients. Dr Lynam-Lennon's work has resulted in a number of important publications and she has been awarded over € 1.1 million in funding as a PI. Dr Lynam-Lennon is also actively involved in science education and outreach. She is currently Treasurer of the Irish Radiation Research Society and a founding and current member of the Irish Association for Cancer Research Junior council.
Dr Sarah McGarrigle
Research Area: Breast Cancer
Contact: firstname.lastname@example.com
Dr Sarah McGarrigle graduated with a BSc (hons.)in Biochemistry from University College Dublin in 2003. She completed her PhD in the Royal College of Surgeons in 2007 which focused on investigating the role of homocysteine and its thiolactone derivative in promoting platelet activation and thrombosis. She joined the Dept. of Surgery, Trinity College Dublin in 2009 as the upper gastrointestinal biobank manager. In 2011 she joined the laboratory of Prof. Elizabeth Connolly to establish and co-ordinate the departmental breast Cancer Research Program. In addition to her role as a researcher, she actively lectures on the MSc in Translational Oncology and BSc in molecular Medicine courses in Trinity College Dublin.
Research Summary:
Our group's major research interest involves investigating the role of lifestyle factors including obesity and its associated metabolic syndrome in breast cancer initiation and progression. A major focus of our group is investigating the potential to reduce breast cancer risk in women with a germline BRCA 1/2 mutation. To this end we are conducting a prospective study to investigate predictive and modifiable risk factors for the development of breast cancer in a cohort of BRCA mutation carriers. This project will also examine the effect of these lifestyle factors surrogate markers of cancer risk including telomere length and oxidative stress in this patient cohort. In addition we are currently investigating the molecular events involved in driving the development and progression of sporadic breast cancer in the context of obesity and the metabolic syndrome. Of particular interest is the role of mammary adipose tissue in this disease. This project will also examine how obesity and the metabolic syndrome affect this adipose tissue depot. Central to our research, we maintain a breast cancer blood and tissue biobank of high quality samples linked to up to date clinical information. This biobank provides us with the patient material necessary to meet our research objectives.
Influence of modifiable lifestyle factors on breast cancer risk in BRCA mutation carriers.
Role of mammary adipose tissue in driving breast tumour progression.
PIK3CA mutations in obesity associated breast cancer (collaboration with Prof. Bryan Hennessy & Dr. Sinead Toomey).
Role of vitamin D in obesity associated breast cancer (collaboration with Prof. JoEllen Welsh University at Albany, New York).
Familial breast cancer, BRCA mutations, Lifestyle factors, Biomarkers, telomere length, oxidative stress, adipose tissue, obesity, metabolic syndrome.
Dr Susan Kennedy
Research Area: Colorectal & Oesophageal Cancer
Contact: firstname.lastname@example.com
Gillian Barber
Research Area: Inflammation & Oesophageal Cancer
Contact: email@example.com
PhD Title: Investigating the role of the inflammatory caspases during the progression to Barrett's oesophagus and Oesophageal Adenocarcinoma.
Gillian's research project examines oesophageal cancer and how it develops. There are many factors that are thought to lead to developing cancer and one such factor is inflammation that arises in gastric reflux (heart burn) and Barrett's oesophagus. These conditions can cause a low inflammation that happens over a long time period. Over time, the constant inflammation can cause damage to the oesophagus and lead to abnormal functions within some cells.
Her project aims to understand this inflammation better. With better understanding we can then develop drugs that can reduce inflammation before the cancer develops.
The second part of her project studies obesity in oesophageal cancer patients. The relationship between obesity and inflammation is well known and Gillian is examining this relationship to understand how it can progress to oesophageal cancer.
Maria Davern
Research Area: Oesophageal Cancer
Contact: firstname.lastname@example.com
PhD Project title: Investigating the applicability of novel cancer immunotherapies in upper gastrointestinal cancers and the impact of concurrent combination chemotherapy.
Maria Davern graduated with a B.Sc. double honours degree in chemistry and biology from Maynooth University in 2016. She then went on to graduate with an M.Sc. in Translational Oncology in 2017 in the Department of Surgery in the Trinity Translational Medical Institute, Trinity College Dublin. Following completion of her M.Sc., Maria was awarded a 2017 Irish Research Council Scholarship to complete a P.hD. under the supervision of Dr. Joanne Lysaght in the Department of Surgery, in the Trinity Translational Medical Institute, Trinity College Dublin, in the area of cancer immunology and immunotherapy. Maria's research is focused on an aggressive type of cancer that affects the lower part of the food-pipe also known as the oesophagus. This type of cancer is rapidly increasing as a result of rapidly increasing obesity levels and is forecast to increase by 140% by the year 2040. Recently, an immunotherapy known as Keytruda was approved in the treatment of this type of cancer. Immunotherapy is a revolutionary new cancer treatment that stimulates the immune system to seek out and destroy cancer cells. This life-changing therapy lacks the harsh side-effects associated with chemotherapy and radiotherapy and has cured cancer in several patients. Unfortunately, only a fraction of patients benefit from immunotherapy. However, many patients receiving immunotherapy would have first received chemotherapy. Therefore, Maria's research involves investigating the effect of chemotherapy on the efficacy of immunotherapy.
Niamh Clarke B.Sc. MSc.
Role: Barrett's Biobank Manager, IBD Research Co-ordinator
Contact: email@example.com
Niamh is currently employed by the Department of Surgery; St.James's Hospital and manages the Barrett's Oesophagus Biobank. This biorespository stores blood and tissue samples from consented patients, combined with health information for use in translational research. Such patient involvement underpins our translational work in the Department. By carrying out cellular and molecular work on these samples we aim to increase our understanding of the development of Barrett's oesophagus, and its possible progression to Oesophageal Cancer. This may lead to new drug targets and treatments for our patients.
Niamh is also currently involved in IBD patient focused research involving Ulcerative Colitis and Crohn's Disease patients. She works closely with a multidisciplinary team and patients alike, in both national and international projects.
Niamh is particularly passionate about science communication and patient and public involvement (PPI) in Research. She especially enjoys the patient interaction and engagement her job involves. She regularly speaks to school students about careers in Science and hopes to increase PPI within the Departments work in the future.
Keywords: Biobanking, Oesophageal Cancer, Barrett's Oesophagus, Ulcerative Colitis, Crohn's Disease, Translational Research, Science Communication, Ethics, Patient and Public Involvement, Clinical Trials.
Prof. Jacintha O'Sullivan
Role: Professor in Translational Oncology, Director of MSc.Translational Oncology
Contact: firstname.lastname@example.com
Prof. Jacintha O'Sullivan is a Professor in Translational Oncology, based at the Trinity Translational Medicine Institute (TTMI), St. James's Hospital. She is the Director of the MSc in Translational Oncology, Education lead for the Trinity, St. James's Cancer Institute and the Education and Outreach Coordinator in TTMI. Jacintha graduated from University College Dublin in 1995 with a first class honours degree in Cell Biology and Molecular Genetics. She then carried out Ph.D. training at the Adrinodack Biomedical Research Institute, Lake Placid, New York and at the University of Notre Dame, Indiana in cancer cell biology. In 2000, she moved to the University of Washington, Seattle as a NIH funded postdoctoral fellow where she investigated how cellular instability events are crucial in driving disease progression in inflammatory diseases and cancer. In 2003, Jacintha returned to Dublin to the Centre for Colorectal Disease, St. Vincent's University Hospital/UCD as a Senior Scientist to establish and direct a translational gastrointestinal research program. She was appointed as Associate Professor in the Department of Surgery, Trinity College Dublin/St. James Hospital in 2010 and promoted to Professor in 2016.
Currently, Prof O'Sullivan directs a translational gastrointestinal (GI) research team in the Trinity Translational Medicine Institute (TTMI) in collaboration with clinical and surgical colleagues. She utilises well established bio-banking structures to drive this GI translational research program. She is internationally recognised in the area of translational gastrointestinal work with many publications in high impact journals and her work has attracted funding from many different sources; Science Foundation Ireland, Health Research Board, Irish Cancer Society, Irish Research Council and from industry collaborators. She has published 3 patents and has graduated a large number of postgraduate Ph.D. and MD students. She is passionate about career mentoring for Ph.D's and research fellows. Prof. O'Sullivan's current translational research themes include;
- Development of diagnostic platforms to stratify cancer risk and response to targeted therapies for gastrointestinal diseases.
- Development of novel patented therapeutics to be used in the neoadjuvant and adjuvant treatment setting for gastrointestinal cancer patients (Colorectal and Oesophageal cancers).
- Elucidating how the tumour microenvironment cross talks to the immune system in GI patients.
- Importance of metabolism, inflammation and obesity in driving disease progression and in regulating treatment response.
The outputs of these translational themes will benefit patient care, treatment and management for gastrointestinal diseased patients.
Dr Graham Pidgeon
Role: Associate Professor in Translational Oncology, Trinity College
Contact: firstname.lastname@example.com
Dr. Graham Pidgeon is an Associate Professor at Trinity College Dublin and a principle investigator at the Trinity Translational Medicine Institute at St. James's Hospital. He established the MSc in Translational Oncology at TCD in 2012 and has acted as Director and Course co-ordinator for that program. Dr. Pidgeon's research interests focus on the molecular pathways linking excess adipose tissue and visceral obesity with tumour development, progression and response to treatment in a range of solid malignancies. The group have a particular interest in the molecular pathways activated in cancer cells within the obese tumour microenvironment, including the activation of immune cell subsets in visceral adipose tissue, alterations in tumour metabolism and how obesity drives the EMT process in solid malignancies. Other areas of interest include the role of bioactive lipid enzymes, including cycloxygenase and lipoxygenase, in tumour cell signalling pathways and metastasis. Recent research has focused on the combination of molecular targeted therapies with chemotherapy and radiation therapy in gastrointestinal cancers. Through national and international collaborations the group are investigating the potential of novel pharmacological and naturally occurring LOX inhibitors as anti-angiogenic and anti-cancer agents. The ultimate aim of this research program is to identify novel therapeutic targets that may prevent the development and/or progression of multiple cancers, through understanding the molecular mechanisms behind the disease.
Jason McGrath
Research Area: MicroRNAs and Pancreatic Cancer
Contact: firstname.lastname@example.com
Anshul Bhardwaj, M.Sc. B.D.S.
Research Area: Upper GI Biobank Manager
Contact: firstname.lastname@example.com
Rebecca O'Brien
Research Area: Colorectal Cancer
Contact: email@example.com
Andrew Sheppard
Research Area: Tumour Immunology
Contact: email@example.com
Andrew graduated from the B.Sc. Human Health and Disease program at Trinity College Dublin in 2015, where he was selected to undertake his research project at the Karolinska Institute in Stockholm, Sweden. Andrew completed a M.Sc. Cancer program at the University College of London's cancer institute. Currently Andrew is completing a PhD on the role of immune cells in Oesophageal Adenocarcinoma funded by the Irish Research Council.


text:
all in
Also found in: Dictionary, Thesaurus, Medical, Financial, Acronyms, Wikipedia.
all in
1. Fully committed to a task or endeavor; giving or prepared to give all of one's energy or resources toward something. Just so you know, I'm all in if you're serious about taking that cross-country trip next week.
2. Betting all of one's money in a card game, such as poker. Once I got my best hand of the night, I went all in.
3. Completely exhausted, fatigued, or worn out. I was all in after only the first mile of the race; I could barely even walk for the rest of it!
all in
completely tired. I'm all in. I need some rest. After their 10—mile hike the campers were all in and very hungry.
all-in1 with everything included. 2 exhausted. British informal
ˌall ˈin
1 (of a price) with nothing extra to pay; inclusive: The trip cost $550 all in. ♢ These are all-in prices — room, breakfast, service and tax.
2 (old-fashioned, informal) very tired: At the end of the race he felt all in.
all in
1. Tired; exhausted.
2. Games Staking all of one's chips, as in poker.
3. Putting all of one's available resources into an effort: The governor mounted a halfhearted campaign for the presidency but didn't go all in.


text:
Brett Battles, thriller writer, hard-working dad and friend of this blog (see Brett Battles interview at right) has come out with another exciting Jonathan Quinn adventure. This time out, Quinn, a "cleaner," must find a body hidden in a wall in London twenty years ago--before the building is demolished. But that's just the beginning of Quinn's problems . . .
What I like about Battles' novels is that he often begins from a female point of view. Therefore, a woman like me, who might be reluctant to pick up the book because I think it's somehow a man's tale, will be lured in by the female character and her dilemma, and then I'm just caught by the narrative.
I haven't yet finished THE SILENCED, but I greatly enjoyed SHADOW OF BETRAYAL, the third Quinn adventure, and Battles really seems to be hitting his stride with this series.
Next on the reading pile: Donna Leon's A QUESTION OF BELIEF. I have never read a Commissario Brunetti mystery, and my mystery friends think less of me for it. Donna Leon was in my town a few years ago, and I didn't go to see her because I'd never read her work (foolish, I know). I'm sure once I read this I'll regret that decision.


text:
Advanced NOx Reduction and OFA Technology
Ammegen is a pioneer in providing cost-effective NOx emissions solutions across a wide range of combustion processes. Our advanced over-fire-air (OFA) and selective non-catalytic reduction systems are the core of our NOx emissions reduction portfolio.
These systems are custom engineered to your unique application and can be applied individually or in combination with a range of integrated systems to ensure compliance with your specific and evolving needs. Our systems are customised to fit each client's unique system properties and plant configuration. CFD combustion modelling is a vital element in our design evaluation and optimisation, used to support the development of your tailored solution.
Our Approach to OFA
- In conjunction with burner replacement or upgrades
- OFA and/or advanced boosted or hybrid OFA depending on NOx reduction requirements
- Customised design to fit specific furnace configuration
- CFD combustion modelling to locate the OFA nozzles
- Maximising NOx reduction whilst maintaining or improving combustion performance
Below: CFD combustion models of baseline and boosted OFA for a 600MW wallfired furnace.
- Overview
- Combustion Optimisation via Improved Fuel/Air Distribution
- Fuel Flow Measurement and Control
- Advanced Combustion Modelling
- Advanced NOx Reduction and OFA Technology
- SNCR Technology
- Fuel Switch Design (Coal to Gas or Biomass)
- Sorbent Injection Systems
Products & Services
VARB & Control Gate PF Balancing System
GravMaster Gravimetric Coal Feeder
CoalFlo Multi-Outlet Classifier PF Balancing Damper
PfMaster Pulverised Fuel Monitoring System
GA202 Boiler Steam Leak Detection System
G-CAM Carbon-in-Ash Analyser for Flue Gas
H-CAM Carbon-in-Ash Analyser for Hoppers


text:
I've literally sat here and attempted to write this blog post for over 1 hour. I'm not kidding. My stomach aches trying to do it. I type a couple sentences, then backspace. I type a line or two, then backspace. There's no great way to get this all out, to put it in to words.
So bear with me.
More than once here on Cheers, Laine, I have told everyone how I believe in fate, and I believe in following your heart. It sounds all fine and dandy until you actually do it.
I have been in a long distance relationship for nearly two years. He's the best. You first met him (Kris) in my post, Momma Knows Best, But You Don't Have To Listen to Her. Then you read my sappy post, I Can Live Without You, where I basically tell him I can, but don't want to.
And during this whole time, we've loved from a distance, knowing well that one of us would eventually make the move.
And that day has come.
I know what you're thinking, miss "Go Fort Wayne," "I'm never leaving," is a hypocrite. How can she promote a city and be as involved as she is, then just up and leave?
I thought that too, at first. How can I leave a place where I've put my heart and soul in to it? How can I leave this place where all my family and friends are? How can I leave this place that made me who I am? Believe me, all the doubt and questions and thinking has gone through my head over and over and over again.
Then I remember I love him more than all of that.
I believe in following your heart. I believe in giving it a shot because it may change your life. And shit, if it doesn't work out it doesn't work out (mom, save me a spot on the couch). But at least I'm trying. At least I'm saying I gave it a go, and really put myself out there.
Now, do I think I owe anyone any type of explanation? No. Maybe I'm writing this to make myself feel better. I don't know. I just know that leaving my hometown, leaving this place I've worked so hard to make a name for myself in, is what I want to do.
I chatted with a friend today about moving, telling her I'm leaving everything I know and everything I've worked for behind. And you know what she told me?
"But you are going to a new awesome place with an awesome person and you definitely worked for those things too."
She is so right. (Thanks, Lauren).
As sad as I am to leave my home, I am so excited. I keep telling people it's this extreme sadness and extreme happiness all at once. Those are not easy emotions to process at the same time.
I am about to leave a city I love for a man I love more. And that is how I want to live my life, by choosing love.
There will always be another Fort Wayne out there for me to jump in and make an impact. But I won't always have this opportunity to go and follow my heart.
So, what the hell?!? Kris and I have never lived in the same city before while dating. Why not live in the same city, live in the same apartment, and while we're at it, let's work together.
Bring it on Bloomington, Indiana.
Bring it on Cook Pharmica.
Laine is headed your way! (Kris, brace yourself).
But Fort Wayne, never forget… You will always have my heart.


text:
Now come on let's face it, whose excitement level doesn't perk up when you hear that slot title alone? Playtech's Cowboys and Aliens slot is one for those of us who like our adventure delivered on the big n' brash scale.
This is a game that pits you, the player, and a cast of other tough nuts as the last hope in town, well on this planet anyway. Here in a dusty cowboy town we, the tough time reel riding cowboys of the title, are out to save the world from a band of menacing aliens- of course. What a combo!
This game from Playtech- the people behind the Top Trumps Celebs slot – looks like a comic book, just like the original that inspired the movie of the same name. The styling is all graphic novel with its hand-drawn look and feel and its retro touches. I had something more high-tech in my mind when I heard the title but it's partially the comic book theming that makes this game something out of the ordinary.
The soundtrack lulls the player into this dustbowl town setting, there's a twanging guitar and harmonica readying us the battle we're about to stage on the reels. Once your wins start, expect a cowboy jig to break the tension and bring those coins home.
Cowboys and Aliens is a five reel, 3 rows and 9 payline slot. If you want more pay-lines, head to something like the Ace Ventura Pet Detective slot, or Gladiator.
So you know that something is about to happen as soon as you see those reels. They're set against a bleached out main street in the middle of the desert which has already seen a high noon battle or two, all broken woodwork and debris.
The icons are all animated graphics from the comic action adventure book heyday. Here the important icons are our pals in planet protection, the main dude a cowboy (he'd appreciate our Golden Mane slot machine), a preacher man, a cowgirl, and a Native American- the exception a scary green-faced alien. The other icons are the A through 10 of the card pack.
The Wild is a dramatic fiery alien spacecraft and the Scatter is the game's logo. The Bonus icon is an alien riding a small hovering machine.
If you get 3 of the Scatter icons, the game logo, will get you a healthy 8 spins all for free. These spins add a little sweetener to the end of the world; each spin adds a Wild to the mix, increasing the odds of a win.
If you can grab the Bonus icon on reels 1 and 5 you trigger the Alien Attack Bonus, this means you get your moment to get those bad guy Martians. YES!
You choose which of 3 heroes you use to try to dispatch 3 Martians based on the skills, weapon and ammo of your character of choice. If can choose the dude/ette for the job then you can go on to win further prizes.
There's one more treat in store. Watch out for the Alien Weapon Feature. In this mode an alien weapon icon that turns up on reel 1. When this appears you'll notice that the weapon picks a number 1-4 on the gun's barrel. This number of shots will then take out random symbols on the reels 2-5 (not the Wild or Scatter) turning those spots into Wilds.
I loved the comic book look and feel. I do love a good 'get the Martians' game and Cowboys and Aliens slot is just the territory for a good old slot time shoot out. I'll be back to take on the bad green guys again soon!
Casino.com remains one of our favourite Playtechs. A big bonus and a big range of games.
Ace Kingdom was a slots casino designed for all screen sizes from Ladbrokes. It has now been discontinued. All links redirect to Ladbrokes.
Fantastic 80s arcade themed slot from Thunderkick with entertaining bonus rounds and wild features. As the slot says...Nice! Awesome! Great!
The Lost Vegas slot has 2 modes: Survivor Mode and Zombie mode. Bag Free Spins with 3 or More Scatters
Join the girls on a night out on the Toon!
A mythical slot with 4 Furious Features including Age of Light free spins and Age of Endurance wilds.
With the Age of Gods jackpot, which includes the Power, Extra Power, Super Power and Ultimate Power jackpots.
and 3 to 5 map symbols to get into the "Click Me" bonus round with an oasis of prizes to be won. Play on your mobile and on desktop.


text:
Discover the best furniture for every area of your house and office
Our Services
From design to consulting, from specialized services for architects and contract, to customized projects: all our projects are unique and inimitable.
Luxury Furniture
The most exclusive brands, the skilled artisan workings, the most refined furnishings.
Our proposals for the most prestigious residences.
Our proposals for the most prestigious residences.
Posted 15 December 2015 966 0 0READ MOREREAD MORE
Request a quote
Our expertise consulting at your service. Rely on us for the decoration of your home or office.
Choose an all Italian skill.
Discover the last news and updates on furniture for your house and office.
Our offers, discounts and promotions of the best furnishings in our showroom.
Discover the news!
Discover the news!